| Followers | 70 |
| Posts | 1643 |
| Boards Moderated | 1 |
| Alias Born | 01/27/2012 |
Tuesday, May 22, 2012 2:43:45 PM
Is this still true?
And, does it really matter at this point based on this comment from you previously?
BTW...here is your link you are looking for
http://www.prweb.com/releases/prweb2012/5/prweb9521567.htm
What drew my attention to ATRN is that Aaron Baker is a graduate of West Point. I learned at West Point to trust my fellow alumnus. I will be in this for the long haul.
And, does it really matter at this point based on this comment from you previously?
My investor group will enter at $.50. They will not buy anything below.
BTW...here is your link you are looking for
http://www.prweb.com/releases/prweb2012/5/prweb9521567.htm
Recent PTIX News
- Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 • ACCESS Newswire • 03/17/2026 12:00:00 PM
- Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market • ACCESS Newswire • 03/10/2026 12:00:00 PM
- Results from Phase 1 Multiple-Dose Study of PT00114 • ACCESS Newswire • 12/09/2025 01:46:00 PM
- Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice • ACCESS Newswire • 11/27/2025 08:45:00 AM
- Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study • ACCESS Newswire • 11/13/2025 01:22:00 PM
- Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates • GlobeNewswire Inc. • 07/30/2025 12:30:00 PM
